A carregar...
Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A
Turoctocog alfa is the first B-domain-truncated third generation recombinant coagulation factor VIII (FVIII) product. Nonclinical in vitro and animal model studies have demonstrated that turoctocog alfa has similar functional potency and hemostatic efficacy as comparator FVIII products. With respect...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378277/ https://ncbi.nlm.nih.gov/pubmed/25848213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S57967 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|